NorthWest Biotherapeutics Inc (NWBO)

[evanstony]

Interesting conviction on company value.

My take on both 1 & 2 of your reasons rely on a small or non existent increase in value for the future worth of the proprietary vaccines and applications. The extension of life for 25% plus of the cancer patients will IMO increase the value of NWBO from a low $150 Million plus or minus with all warrants at today's price to $2 Billion dollars plus... If 35% OS is achieved add significantly more.

Seeing the interim Blinded data, #3, will definitely show results of a life extension or it will not. IMO reading the tidbits of released data from last year indicate an improvement of 50% over SOC which means more than 36 months OS and many passing 60 months.

My hope is two fold. Help for cancer patients and LP stays the course and we do not have a BO but grow to serve patients. Surviving this long has already been miraculous. With good results the next phase seems not nearly as difficult.